DOCSLIB.ORG

Keyword Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Keyword Index Neuropsychopharmacology (2012) 38, S479–S521 & 2012 American College of Neuropsychopharmacology. All rights reserved 0893-133X/12 www.neuropsychopharmacology.org S479 Keyword Index 10b-Hydroxyestra-14-diene-3-one . W87 M114, M115, M116, M119, M123, M130, M131, M132, M134, M140, M142, 13C magnetic resonance spectroscopy . W34 M143, M144, M145, M146, M149, M150, M151, M152, M154, M155, M156, M157, M158, M159, M166, M168, M172, M174, M178, M179, M181, M182, 22q11 deletion . T123 M185, M186, M187, M188, M193, M197, M198, M199, M200, M201, M202, 2-AG . .23.2, 23.3, M145, T69, T161 M205, M212, T3, T5, T8, T13, T16, T17, T20, T22, T24, T25, T27, T31, T35, 3-MT . M182 T44, T49, T51, T58, T60, T66, T67, T72, T75, T77, T79, T80, T82, T83, T86, T88, T91, T95, T98, T99, T103, T109, T111, T113, T114, T116, T117, T119, 5-HT . 14.2, 17.4, 44.2, 52, M19, M45, M64, M72, M75, M91, T121, T125, T126, T128, T138, T140, T144, T147, T148, T151, T153, T154, M115, M144, M147, M154, M157, M161, M162, M183, M185, M186, T17, T49, T158, T161, T166, T167, T171, T173, T176, T177, T179, T181, T185, T188, T53, T120, T163, T194, W54, W125, W165, W176, W191 T189, T192, T194, T197, T198, T202, T203, T209, T210, W3, W5, W8, W10, 5-HT6 . .W125 W18, W20, W31, W32, W45, W46, W53, W54, W57, W64, W71, W72, W75, W76, W81, W83, W84, W87, W93, W94, W97, W100, W103, W104, W105, A W106, W107, W115, W116, W117, W118, W120, W124, W129, W137, W138, W143, W154, W158, W159, W160, W169, W172, W173, W176, W177, W186, W188, W195, W197, W199, W201, W203, W208, W214, W218 AAV . 8.3, 34, 49, M7, M18, M29, M79, activity-dependent phosphorylation . M77 M115, M198, M201, T156, T157, W46, W97 acute tryptophan depletion . .M162, T49, W54 ABA . 17, 22.2, 37.2, 39.3, 39.4, 45, 45.4, 49, 55.4, ADAR................................................44 M6, M11, M28, M43, M48, M55, M59, M69, M83, M91, M93, M115, M119, M123, M144, M147, M152, M157, M160, M171, M179, M190, M194, M199, ADCYAP1R1 . .T10, T11 M201, M203, T27, T46, T52, T56, T70, T84, T96, T109, T124, T183, T202, addiction . 1.2, 2.2, 4.2, 8.3, 14.3, 15.4, 19.2, 22, 22.2, W32, W34, W84, W86, W104, W109, W139, W160, W197, W217 22.3, 31, 32, 35, 37.2, 45.2, 45.3, 45.4, 49, 49.2, 49.4, 54.2, 54.4, 55.2, 56.2, M11, abdominal obesity . T26, W138, W188 M15, M39, M45, M48, M56, M62, M71, M80, M81, M95, M100, M116, M126, M151, M178, M184, M188, M195, M201, M206, T5, T16, T30, T31, T73, T94, abstinence . .14.3, 19.4, 22, 28.2, 31, 31.4, 32.4, T97, T99, T140, T150, T152, T156, T163, T170, T171, T178, T181, T200, 40, 40.3, 45, 49.3, 49.4, M4, M15, M81, M131, M184, M188, M192, T5, T7, T205, T210, W12, W22, W25, W64, W72, W96, W97, W105, W125, W141, T25, T29, T30, T73, T89, T94, T116, T140, T180, W4, W18, W28, W77, W146, W159, W167, W199, W216 W79, W111, W114, W141, W167, W173, W185 add-on . M32, T162, W57, W195 abuse . .1.3, 2.2, 4.2, 8.3, 19.2, 19.4, 22.3, 24, 24.2, 30, 31.4, 32, 32.2, 32.4, 35, 37, 38.3, 40.3, 45.2, 49, 49.2, 53.3, 55, 55.4, 56.4, Adenosine receptor . .M184 M11, M15, M39, M45, M56, M58, M74, M79, M80, M81, M116, M123, M150, ADHD . .4.2, 31, 31.2, 31.3, 31.4, 52, 54.2, M48, M57, M159, M175, M177, M186, M192, M193, M203, M208, T3, T6, T16, T35, T86, M159, M163, T17, T41, T44, T49, T82, T99, T104, T109, T154, T157, W8, T89, T94, T102, T108, T111, T119, T120, T126, T140, T143, T150, T156, T178, W54, W70, W144, W158, W201, W218 T180, T189, T196, T200, T203, T206, T208, T214, W8, W18, W21, W28, adolescence . 2.2, 4.4, 7.2, 19, 19.3, 20.4, 24.2, 46.2, 46.3, 55, 55.2, W38, W48, W73, W78, W90, W106, W129, W131, W136, W145, W147, 55.3, 55.4, M15, M49, M58, M61, M62, M64, M83, M87, M127, M138, M139, W155, W169, W170, W173, W180, W189, W199, W201 M144, M148, M163, M181, T11, T27, T82, T87, T129, T154, T157, T168, T174, Abuse Liability . 45.2, W155, W169 T177, T200, W36, W89, W98, W118, W121, W133, W134, W139, W150, ACC . 1.2, 4.3, 16.2, 19, 41.3, 46.2, 52.4, M31, M42, W158, W206 M139, M173, M194, M209, T71, T75, T77, T78, T80, T82, T84, T96, T97, adolescent . 2.2, 4.3, 4.4, 7.3, 19, 19.2, 19.4, 20.4, T98, T109, T111, T112, T116, T118, T145, T167, T172, T175, T187, T191, T192, 24, 24.2, 24.3, 41.4, 46.3, 48, 50.2, 50.4, 52.2, 55, 55.2, 55.3, 55.4, M15, M24, W35, W105, W126, W172, W206 M37, M49, M58, M61, M62, M87, M88, M94, M95, M136, M139, M140, M148, M175, M181, T11, T41, T84, T87, T97, T101, T109, T129, T154, T167, accuracy . .20.3, M34, M48, M92, M112, M136, M151, T57, T106, T157, T160, T179, T181, T183, T184, T193, T197, T207, T168, T172, W36, W56, W62, W80, W89, W98, W110, W118, W121, W133, T213, W52, W76, W88, W111, W123, W154, W162, W197, W200, W205 W134, W139, W206 adolescents . .4.3, 4.4, 19, 19.4, 20.4, 24, 24.3, 41.4, acetylation . .M71, M77, M110, T176 46.3, 48, 50.2, 50.4, 52.2, 55, 55.2, M24, M37, M136, M139, M140, M148, acetylcholine . 39.4, 47.3, M3, M103, M126, M127, M175, T11, T41, T84, T87, T97, T109, T129, T167, T168, T172, W56, W62, M153, M157, M188, T68, T74, T100, W4, W28 W80, W89, W98, W110, W121, W133, W134, W206 acetylcholinesterase inhibitor . T74, W4 Adrenocorticotropic Hormone . .W13 ACTH . 16.2, 32.2, M21, M65, M101, adult . 2.2, 2.3, 4.3, 4.4, 8.4, 16, 16.2, 16.3, 16.4, 17.3, M131, M133, T10, W13, W90 19.2, 19.3, 19.4, 20.4, 21.2, 24.2, 24.3, 27.3, 28.2, 30.3, 31.2, 31.3, 31.4, 36.2, activity . 1.2, 2.2, 3.4, 4, 4.2, 4.4, 6.3, 7.2, 7.3, 39.4, 41.2, 41.4, 42, 45.2, 46.3, 47, 48, 48.2, 48.3, 50.2, 52, 53.2, 55, 55.2, 55.3, 7.4, 8.3, 8.4, 15.4, 16, 16.2, 16.3, 17.2, 18, 19.2, 19.4, 22.3, 23.3, 23.4, 24, 24.3, 55.4, M3, M14, M22, M30, M37, M42, M43, M49, M57, M58, M61, M62, 25.2, 25.4, 27, 28.2, 29.3, 30, 30.4, 31, 31.2, 31.3, 31.4, 33, 33.2, 34, 34.3, 34.4, M64, M74, M75, M82, M83, M84, M87, M93, M103, M116, M117, M119, 36.3, 37.2, 39, 39.4, 40.2, 40.3, 44.2, 44.3, 45.2, 45.3, 46.4, 47.4, 49.2, 49.3, M127, M131, M134, M138, M141, M144, M148, M151, M159, M162, M167, 50, 50.3, 50.4, 51.4, 52.3, 53, 53.3, 54.2, 54.3, 55, 55.3, 55.4, 56, 56.2, 56.4, M6, M174, M204, M209, T4, T6, T7, T13, T15, T18, T22, T23, T27, T35, T45, M7, M9, M12, M13, M14, M15, M16, M17, M19, M20, M23, M29, M31, M34, T49, T57, T71, T77, T78, T80, T82, T83, T87, T93, T97, T99, T104, T105, M35, M38, M39, M42, M43, M44, M45, M46, M48, M49, M50, M55, M56, T108, T109, T110, T117, T123, T126, T127, T129, T131, T134, T147, T151, T155, M57, M60, M61, M63, M66, M67, M68, M72, M75, M76, M77, M80, M83, T157, T161, T164, T168, T174, T177, T184, T196, T200, T213, T214, W3, W7, M84, M86, M91, M95, M96, M99, M100, M101, M106, M108, M109, M110, W8, W11, W16, W26, W27, W30, W36, W43, W48, W55, W56, W62, W65, ACNP 51st Annual Conference Keyword Index S480 W67, W73, W75, W83, W93, W99, W104, W106, W110, W113, W114, W117, T3, T8, T11, T25, T48, T83, T97, T99, T102, T107, T119, T124, T146, T150, W118, W121, W126, W131, W134, W139, W145, W151, W156, W158, W163, T153, T161, T170, T173, T178, T188, T200, W8, W11, W21, W25, W32, W36, W168, W170, W171, W200, W201, W210 W48, W49, W73, W96, W97, W114, W131, W147, W157, W185, W189, adult neurogenesis . 27.3, 30.3, M74, M82, M93, M117, W214, W217 M174, T4, T22, T155, W104 Alcohol Craving . .M94, T25 affect . 2.3, 3.3, 5.3, 5.4, 15.2, 17.3, 17.4, 18.2, alcohol dependence . .14.3, 32.3, 32.4, 34.2, 40, 40.3, 19.3, 20, 22.3, 23.2, 24, 25, 25.3, 26, 27.2, 27.4, 32, 34, 34.3, 37.2, 38, 39, 39.3, 49.4, M131, M177, M178, M207, T8, T25, T48, T83, T99, T102, T119, T170, 39.4, 40.3, 41.2, 49.2, 49.3, 49.4, 50.3, 51.3, 51.4, 52, 55, 57.3, M4, M5, M6, T173, W25, W48, W49, W96, W114, W157, W185, W189, W214 M7, M11, M18, M19, M24, M25, M26, M28, M29, M32, M39, M41, M51, alcohol drinking . .34.2, 40, 53.3, M40, M67, M53, M55, M61, M66, M73, M74, M78, M84, M88, M91, M92, M93, M106, M86, M94, M95, M143, M207, T25, T153, W36 M109, M110, M114, M115, M116, M117, M118, M120, M121, M122, M124, Alcohol preference.
Load more

Recommended publications
  • Worksop-Inset.Pdf
    Worksop inset map 258 151 43.3m 3 41.8m 139 74 135 ANSTON AVENUE 64 4 SOUTH VIEW 125 AVENUE HARSTOFT 54 3 LB 214 115 42 PCs 31 22 105 40 Shelter 42.4m 13 Supermarket 36 32 El Sub Sta 22 44.5m 1 12 221 81 246 69 2 103 48.2m 37 57 A N S TO N A V E N U E 54 ED & Ward Bdy 52a B L Y TH G R O V E 45 41 Key 33 45.7m 29 23 CR 2 13 STANLEY STREET STANLEY 35 25 3 234 1a3a 1 11 North Nottinghamshire College Shelter 21 5 21 217 (FE) 12 New Housing (ST18) 33 52 12 43 BLYTH ROAD 53 19 222 JA M E S S TR E E T 215 1 G A TE FO R D R O A D 2 Works CR 220 8 Proposed mixed use (Policy 17) 10 54.3m 14 I Ward Bdy 25 13 SP 6 GP 1a 17 1b 208 Shelter 2 1 Committed Housing 36 3 HOLMEFIELD CLOSE HOLMEFIELD 15 43.0m S H E P H E R D 'S A V E N U E 15 2 13 CR Norbridge Academy 29 196 (Sch) 15 PERCIVAL STREET PERCIVAL 38 New Employment (ST08) 2a 24 2 203 L Twrs W52 13 8 1 3 52.4m 10 186 11 S H E P H E R D 'S A V E N U E 34 Pit 18 Wr Pt 9 Exisiting Employment (ST11) SPs 30 12 174 SP 34a M e rry -g o -ro u n d CR 168 28 Locally important openL Twr space (ST48) W ag o n D ep o t The Chestnuts 50.0m 3 El Sub Sta SP Oak Lodge Playingfield and outdoor sportsSandhole Sidings facility (ST49) TU R N E R R O A D 40.0m 20 1 LB El Sub Sta 185 78 Ward Bdy STREET 18 1b 8 CR 1a 102 183 7 Main Green Corridor (ST41) STANLEY 90 72 MP 0.5 50.6m ED Bdy BANK El Sub Sta BLYTH ROAD Turner Road 18a SUNNY ED Bdy TU R N E R R O A D 64 SP Industrial 51.8m Minor Green Corridor (ST41) Estate 18b 54 Club 47.2m 50 Ward Bdy 48.8m 63 61 53 6 50.9m ED Bdy ED & Ward Bdy Ward & ED 49 SUNNY BANK Bowling
    [Show full text]
  • Download Resume
    Curriculum Vitae Full Name: David M. Marks, M.D. Contact: [email protected] Mobile (619) 822-7117 Credentials: Diplomate, American Board of Psychiatry and Neurology (Psychiatry) Subspecialty Certification in Psychosomatic Medicine Diplomate, American Board of Pain Medicine Position Title: Associate Professor Department of Psychiatry and Behavioral Sciences Department of Community and Family Medicine Duke University Medical Center Duke Clinical Research Institute Duke Pain and Palliative Care Clinic Education: Institution & Location Degree Year Conferred Field of Study University of California at San Diego Fellowship 1999 - 2000 Consultation and San Diego, CA Liaison Psychiatry Medical College of Pennsylvania / Senior 1998 - 1999 Psychiatry Clinical Neuroscience Research Unit Resident Philadelphia, PA University of California at San Diego Resident 1995 - 1998 Psychiatry San Diego, CA University of Texas Medical Branch M.D. 1995 Galveston, TX Rice University B.A. 1991 Psychology Houston, TX Research and Professional Experience: Position Institution/Employer & Location Dates of Employment Attending Faculty Physician Duke Pain and Palliative Care Clinic 09/08-present (Chronic Pain Management) Attending Faculty Physician Duke University Medical Center, 07/06-present Inpatient Psychiatric Service, Emergency Service, Consultation/Liaison Service Attending Faculty Physician Durham Regional Hospital, 09/08-07/11 Consultation/Liaison Service Medical Director, Inpatient and Duke University Medical Center 07/06 – 02/07 Emergency Psychiatry Services Medical Director, CNS Division EStudy Site 05/05 -- 07/06 La Mesa, Oceanside, National City CA Chief Executive Officer/Medical Optimum Health Services 01/02 – 05/05 Director La Mesa, Oceanside CA Chief of Staff Alvarado Parkway Institute 01/04 – 01/05 1 La Mesa, CA Page _____________________________________________________________________ David M.
    [Show full text]
  • Discovery World 02/03/2018 TD: Bob Patterson-Sumwalt Participants 155 K12 Participants in Tournaments to Date 17 - 18 1774
    Discovery World 02/03/2018 TD: Bob Patterson-Sumwalt Participants 155 K12 Participants in tournaments to date 17 - 18 1774 No. Name Pts Local Team TBrk1 TBrk2 TBrk3 Rnd1 Rnd2 Rnd3 Rnd4 Rnd5 1 KRAEMER, JOHNATHAN 5.0 1222 PIUSwa 12.0 14.0 15.0 W29 W14 W37 W16 W10 2 CHEN, ALEXANDER 4.5 1354 MEQUON15.5 18.0 14.5 W20 W4 W26 W5 D3 3 NEEB, WILL JR 4.5 1323 GOLDmi 12.5 14.5 14.5 W35 W15 W32 W13 D2 4 NEEB, EMMA 4.0 1153 GOLDmi 14.5 16.5 11.0 W6 L2 W39 W23 W19 5 SURESH, ARJUN 4.0 1155 NORTwa 14.0 16.5 13.0 W11 W25 W23 L2 W14 6 RUPLINGER, AARON 4.0 1222 FRANwe 13.0 14.5 10.0 L4 W18 W45 W22 W17 7 HARWOOD, WILLIAM 4.0 1173 MEQUON12.0 14.5 11.0 W17 L13 W25 W21 W15 8 SCHMIDT, NATHAN 4.0 1123 RIVEmi 12.0 14.5 10.0 L15 W21 W28 W18 W13 9 SHANMUGASUNDARAM, TANYA4.0 1014 NORTme 10.5 12.5 10.0 L13 W27 W38 W32 W16 10 MOLINA, MAXIMUS 3.5 968 UNITmi 14.5 16.0 12.0 W22 D11 W44 W19 L1 11 HANSEN, KEEGAN 3.5 940 GOLDmi 11.5 13.0 8.0 L5 D10 W40 W44 W35 12 PAGEL, CARSON 3.5 921 GOLDmi 10.5 12.0 8.0 L14 D44 W31 W26 W30 13 ORTIZ, DIEGO 3.0 1121 UNITmi 16.5 19.5 12.0 W9 W7 W24 L3 L8 14 MARTINEZ, GUSTAVO 3.0 973 UNITmi 15.5 16.5 10.0 W12 L1 W51 W24 L5 15 ALEXANDER, DELIA 3.0 1008 CARMEN 14.5 15.5 10.0 W8 L3 W50 W33 L7 16 VARELA, JAIRO 3.0 850 UNITmi 14.0 15.0 12.0 W53 W20 W43 L1 L9 17 MORALES, RAFAEL 3.0 948 UNITmi 13.0 15.0 9.0 L7 W28 W27 W43 L6 18 SCHESKE, WILLIAM 3.0 855 GOLDmi 12.0 12.5 9.0 W34 L6 W52 L8 W33 19 SCHOMANN, MADDOX 3.0 800 TEMPsu 11.5 13.5 12.0 W39 W34 W33 L10 L4 20 HARPER, TYRONE 3.0 906 GOLDmi 11.5 13.5 6.0 L2 L16 W41 W34 W32 21 CHAPLIN, CARTER 3.0
    [Show full text]
  • New Drug Evaluation Monograph Template
    © Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 | Fax 503-947-1119 Class Update: Second Generation Antidepressant Medications Month/Year of Review: May 2014 Last Oregon Review: April 2012 PDL Classes: Psychiatric: Antidepressants Source Document: OSU College of Pharmacy New drug(s): vortioxetine (Brintellix®) Manufacturer: Takeda & Lundbeck/Forest levomilnacipran extended-release (Fetzima®) Dossier Received: Yes/Pending Current Status of Voluntary PDL Class: Preferred Agents: BUPROPION HCL TABLET/TABLET ER, CITALOPRAM TABLET/SOLUTION, FLUOXETINE CAPSULE/SOLUTION/TABLET, FLUVOXAMINE, MIRTAZEPINE TAB RAPDIS/TABLET, PAROXETINE TABLET, SERTRALINE ORAL CONC/TABLET, VENLAFAXINE TABLET, VENLAFAXINE ER Non-Preferred Agents: BUPROPRION XL, DESVENLAFAXINE (PRISTIQ ER), DULOXETINE (CYMBALTA®), ESCITALOPRAM, FLUOXETINE DF (PROZAC® WEEKLY), NEFAZODONE, PAROXETINE HCL (PAXIL CR®), SELEGILINE PATCH (ENSAM®), VILAZODONE (VIIBRYD®), OLANZAPINE/FLUOXETINE (SYMBYAX®) Status of the Voluntary Mental Health Preferred Drug List Currently, all antidepressants are available without prior authorization for non-preferred placement. Oregon law prohibits traditional methods of PDL enforcement on mental health drugs. Second generation antidepressants have been reviewed for clinical efficacy and safety and specific agents were chosen as clinically preferred; this eliminates a copay. Oregon’s Medicaid program currently
    [Show full text]
  • Korea Railroad Corporation
    KOREA RAILROAD CORPORATION Issue of U.S.$ 150,000,000 Floating Rate Notes due 2024 (the “Notes”) Issued pursuant to the U.S.$2,000,000,000 Medium Term Note Program Issue Price: 100% of the Aggregate Nominal Amount Issue Date: November 29, 2019 This investor package includes (a) the offering circular dated August 28, 2018 relating to the U.S.$2,000,000,000 Medium Term Note Program (the “Program”) as supplemented by the pricing supplement dated November 18, 2019 relating to the Notes (the “Offering Circular”), and (b) this document dated November 29, 2019 as the cover page to the Offering Circular (the “Investor Package”). The Notes will be issued by Korea Railroad Corporation (the “Issuer”). Application will be made to the Taipei Exchange (the “TPEx”) for the listing of, and permission to deal in, the Notes by way of debt issues to professional investors as defined under Paragraph 1, Article 2-1 of the Taipei Exchange Rules Governing Management of Foreign Currency Denominated International Bonds of the ROC only and such permission is expected to become effective on or about November 29, 2019. TPEx is not responsible for the contents of this Investor Package and no representation is made by TPEx as to the accuracy or completeness of this Investor Package. TPEx expressly disclaims any and all liabilities for any losses arising from, or as a result of, the reliance on, all or part of the contents of this Investor Package. Admission for listing and trading of the Notes on the TPEx is not to be taken as an indication of the merits of the Issuer or the Notes.
    [Show full text]
  • VMAA-Performance-Sta
    Revised June 18, 2019 U.S. Department of Veterans Affairs (VA) Veteran Monthly Assistance Allowance for Disabled Veterans Training in Paralympic and Olympic Sports Program (VMAA) In partnership with the United States Olympic Committee and other Olympic and Paralympic entities within the United States, VA supports eligible service and non-service-connected military Veterans in their efforts to represent the USA at the Paralympic Games, Olympic Games and other international sport competitions. The VA Office of National Veterans Sports Programs & Special Events provides a monthly assistance allowance for disabled Veterans training in Paralympic sports, as well as certain disabled Veterans selected for or competing with the national Olympic Team, as authorized by 38 U.S.C. 322(d) and Section 703 of the Veterans’ Benefits Improvement Act of 2008. Through the program, VA will pay a monthly allowance to a Veteran with either a service-connected or non-service-connected disability if the Veteran meets the minimum military standards or higher (i.e. Emerging Athlete or National Team) in his or her respective Paralympic sport at a recognized competition. In addition to making the VMAA standard, an athlete must also be nationally or internationally classified by his or her respective Paralympic sport federation as eligible for Paralympic competition. VA will also pay a monthly allowance to a Veteran with a service-connected disability rated 30 percent or greater by VA who is selected for a national Olympic Team for any month in which the Veteran is competing in any event sanctioned by the National Governing Bodies of the Olympic Sport in the United State, in accordance with P.L.
    [Show full text]
  • Dr Brandon Doss Assistant State Veterinarian AR Livestock & Poultry
    HATCHERIES, DEALERS, AND INDEPENDENT FLOCKS PARTICIPATING IN THE NATIONAL POULTRY IMPROVMENT PLAN MULTIPLIER MEAT-TYPE CHICKEN BREEDING FLOCKS NPIP. HATCHING PRODUCTS CLASSIFIED ADDITIONAL NO. SUBPART PARTICIPANTS NAME AND ADDRESS EGG U.S. PULLORUM-TYPHOID CLASSIFICATIONS FOR CAPACITY CLEAN WHICH PRODUCTS QUALFIED 71 - Arkansas Dr Brandon Doss Assistant State Veterinarian AR Livestock & Poultry Commission PO Box 8505 Little Rock, AR 72215 Phone: 501-907-2254 Fax:501-907-2259 [email protected] Hatchery Farm/company George's Inc. #1 P.O. Box G Springdale, MGM MSM AI 24 C AR 72764 T CLEAN P/T CLEAN Phone: OK Farms P.O. Box 1119 Ft. Smith, MGM MSM AI 121 C AR 72902 T19 T3 CLEAN P/T CLEAN Phone: Ozark Mountain Poultry farms, LLC 1420 MGM MSM AI 183 C St Louis St Batesville, AR 72503 T CLEAN P/T CLEAN Phone: Peco Foods 1600 White Drive Batesville, MGM MSM AI 108 C AR 72501 T CLEAN P/T CLEAN Phone: Pilgrim's Pride Corp. P.O. Box MG MS AI CLEAN P/T 189 C 811 Nashville, AR 71852 T CLEAN Phone: Simmons Foods Inc. P.O. Box 430 Siloam MGM MSM AI 185 C Springs, AR 72761 5503680 T9 T19 CLEAN P/T CLEAN Phone: Tyson Foods Inc. 1115 South MGM MSM AI 175 C Elmira Russellville, AR 72801 T CLEAN P/T CLEAN Phone: Tyson Foods Inc. P.O. Box 576 Green 221 C Forest, AR 72638 T AI CLEAN P/T CLEAN Phone: Tyson Foods Inc. P.O. Box 219 C 507 Murfreesboro, AR 71842 T AI CLEAN P/T CLEAN Phone: Tyson Foods Inc.
    [Show full text]
  • National Poultry Improvement Plan
    Historic, archived document Do not assume content reflects current scientific knowledge, policies, or practices. Jius / / d T(o TJz £f\ United States ^«& Department of Agriculture National Poultry _ Animal and _ -}— Plant Health Inspection Improvement Plan Service Veterinary Services 1981 Directory of Participants APHIS 91-42 Handling Waterfowl, February 1 981 Exhibition Poultry, and Game Birds NATIONAL POULTRY IMPROVEMCNT PLAN U.S. J U.S. | Jush [Pullorum-Typhoic 7 S M.Gollisepticum ^ APPROVED m TCLEANj * *! CLEANF npip! ^H^IPB^pV BJ B* The National Poultry Improvement Plan became operative July 1, 1935, and the National Turkey Improvement Plan became operative September 25, 1943, with the approval of the Secretary of Agriculture. On December 3, 1971, the two Plans were combined under one title, "The National Poultry Improvement Plan," with separate provisions applicable to the different types of poultry. The Plan operates under the authority of an appropriation made by Congress to the United States Department of Agriculture to be used in cooperation with the State authorities in the administration of regulations for the improvement of poultry, poultry products, and hatcheries. Authority for the administration of the Plan is now contained in the Department of Agriculture Organic Act of 1944, as amended (7 U.S.C. 429). Provisions of the Plan are changed from time to time to conform with the development of the industry and with new information as it becomes available. These changes are based on recommendations made at the Biennial National Plan Conferences by official delegates representing participating breeders, hatcheries, and flockowners from all cooperating States. Current provisions of the Plan are described in a publication entitled "The National Poultry Improvement Plan and Auxiliary Provisions." The publication is available from Official State Agencies or on request to the National Poultry Improvement Plan, APHIS-VS, Building 265, BARC- East, Beltsville, Maryland 20705.
    [Show full text]
  • Heater Element Specifications Bulletin Number 592
    Technical Data Heater Element Specifications Bulletin Number 592 Topic Page Description 2 Heater Element Selection Procedure 2 Index to Heater Element Selection Tables 5 Heater Element Selection Tables 6 Additional Resources These documents contain additional information concerning related products from Rockwell Automation. Resource Description Industrial Automation Wiring and Grounding Guidelines, publication 1770-4.1 Provides general guidelines for installing a Rockwell Automation industrial system. Product Certifications website, http://www.ab.com Provides declarations of conformity, certificates, and other certification details. You can view or download publications at http://www.rockwellautomation.com/literature/. To order paper copies of technical documentation, contact your local Allen-Bradley distributor or Rockwell Automation sales representative. For Application on Bulletin 100/500/609/1200 Line Starters Heater Element Specifications Eutectic Alloy Overload Relay Heater Elements Type J — CLASS 10 Type P — CLASS 20 (Bul. 600 ONLY) Type W — CLASS 20 Type WL — CLASS 30 Note: Heater Element Type W/WL does not currently meet the material Type W Heater Elements restrictions related to EU ROHS Description The following is for motors rated for Continuous Duty: For motors with marked service factor of not less than 1.15, or Overload Relay Class Designation motors with a marked temperature rise not over +40 °C United States Industry Standards (NEMA ICS 2 Part 4) designate an (+104 °F), apply application rules 1 through 3. Apply application overload relay by a class number indicating the maximum time in rules 2 and 3 when the temperature difference does not exceed seconds at which it will trip when carrying a current equal to 600 +10 °C (+18 °F).
    [Show full text]
  • View of the Algorithm Will Be Discussed Below to Summarize the Key Points of the Algorithm
    EFFECTIVE NONLINEAR SUSCEPTIBILITIES OF METAL-INSULATOR AND METAL-INSULATOR-METAL NANOLAYERED STRUCTURES Dissertation Submitted to The School of Engineering of the UNIVERSITY OF DAYTON In Partial Fulfillment of the Requirements for The Degree of Doctor of Philosophy in Electro-Optics By Mallik Mohd Raihan Hussain Dayton, Ohio May, 4242 EFFECTIVE NONLINEAR SUSCEPTIBILITIES OF METAL-INSULATOR AND METAL-INSULATOR-METAL NANOLAYERED STRUCTURES Name: Hussain, Mallik Mohd Raihan APPROVED BY: Imad Agha, Ph.D. Andrew Sarangan, Ph.D. Advisory Committee Chairman Committee Member Associate Professor, Department of Professor, Department of Physics, and, Department of Electro- Electro-Optics and Photonics Optics and Photonics Partha Banerjee, Ph.D. Michael Scalora, Ph.D. Committee Member Committee Member Professor and Department Chair, Research Physicist, Charles M. Department of Electro-Optics and Bowden Research Facility, Photonics AMRDEC, US Army RDECOM Robert J. Wilkens, Ph.D., P.E. Eddy M. Rojas, Ph.D., M.A., P.E. Associate Dean for Research Dean, School of Engineering and Innovation Professor, School of Engineering ii © Copyright by Mallik Mohd Raihan Hussain All rights reserved 4242 ABSTRACT EFFECTIVE NONLINEAR SUSCEPTIBILITIES OF METAL-INSULATOR AND METAL-INSULATOR-METAL NANOLAYERED STRUCTURES Name: Hussain, Mallik Mohd Raihan University of Dayton Advisor: Dr. Imad Agha Nonlinear electromagnetic radiation (second and third harmonic) from the metal-insulator and metal-insulator-metal structures were measured and compared against predictions from the hydrodynamic models of plasmonics. This model incorporated higher order terms stem- ming from electron tunneling and nonlocality. This study shows that, besides the linear optical parameter like permittivity, conductivity etc, changes in the nonlinear optical pa- rameters, namely, second and third order susceptibilities (χ(2) and χ(3), respectively) can also be used to probe and compare the higher-order terms of the hydrodynamic model of plasmonics.
    [Show full text]
  • Petitioner's Exhibit 17
    JURC PETITIONER'S EXHIBIT 0.~~.....L--- Petitioner's Exhibit 17 7 TOWN OF CEDAR LAKE Preliminary Engineering Report Cedar Lake Water Utility System Improvements July 2020 Prepared by: !,?.!! !!e.!,~JI ~ •• !.'!!; ru.E.~~ ~ Ph: (219) 844 8680 • Fax: (219) 844 7754 · e-mail: [email protected] Your Vision • Our Focus Table of Contents 1. Project Location ............................................................................................................................................ 6 2. Current Needs ............................................................................................................................................... 6 2.1. Existing System ...................................................................................................................................... 6 2.1.a. Distribution System ....................................................................................................................... 6 2.1.b. Supply System ............................................................................................................................... 7 2.1.c. Storage System ............................................................................................................................. 8 2.1.d. Treatment Systems ....................................................................................................................... 8 2.1.e. Document Needs .........................................................................................................................
    [Show full text]
  • Athletics Classification Rules and Regulations 2
    IPC ATHLETICS International Paralympic Committee Athletics Classifi cation Rules and Regulations January 2016 O cial IPC Athletics Partner www.paralympic.org/athleticswww.ipc-athletics.org @IPCAthletics ParalympicSport.TV /IPCAthletics Recognition Page IPC Athletics.indd 1 11/12/2013 10:12:43 Purpose and Organisation of these Rules ................................................................................. 4 Purpose ............................................................................................................................... 4 Organisation ........................................................................................................................ 4 1 Article One - Scope and Application .................................................................................. 6 International Classification ................................................................................................... 6 Interpretation, Commencement and Amendment ................................................................. 6 2 Article Two – Classification Personnel .............................................................................. 8 Classification Personnel ....................................................................................................... 8 Classifier Competencies, Qualifications and Responsibilities ................................................ 9 3 Article Three - Classification Panels ................................................................................ 11 4 Article Four
    [Show full text]